Sentara Greenbrier Diagnostics is categorized under Hospitals in Chesapeake, VA .
Sentara Greenbrier Diagnostics was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 6215120 by the NAICS.
If you are seeking more information, feel free to contact Verlon Salley, Administrator at the company’s branch by writing to 713 Volvo Parkway # 105, Chesapeake, Virginia VA 23320 or by phoning (757) 282-4025. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sentara Greenbrier Diagnostics |
| Contact Person: | Verlon Salley, Administrator |
| Address: | 713 Volvo Parkway # 105, Chesapeake, Virginia 23320 |
| Phone Number: | (757) 282-4025 |
| Website Address: | sentara.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 6215120 |
| Share This Business: |
Sentara Greenbrier Diagnostics was started in 0 to provide professional Hospitals under the SIC code 8062 and NAICS code 6215120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Verlon Salley, Administrator for inquiries that concern Sentara Greenbrier Diagnostics by calling the company number (757) 282-4025, as your correspondence is most welcome. Additionally, the physical location of the branch of Sentara Greenbrier Diagnostics can be found at the coordinates 36.76738,-76.23471 as well as the street address 713 Volvo Parkway # 105 in Chesapeake, Virginia 23320.
For its online presence, you may visit Sentara Greenbrier Diagnostics’s website at sentara.com and engage with its social media outlets through on Twitter and on Facebook.